KariLynn Dowling
PharmD, Community Pharmacy Practice Research Fellow
Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, is a Community Pharmacy Practice Research Fellow and adjunct faculty member at East Tennessee State University (ETSU) Gatton College of Pharmacy. She is a 2014 graduate of the University of Montana Skaggs School of Pharmacy. She completed residency training at Penobscot Community Health Care in Bangor, Maine, as a member of the 2014-15 PGY1 Community Pharmacy and 2015-16 PGY2 Health-Systems Pharmacy Administration residency classes. As a resident, Dowling focused on controlled substance stewardship and program implementation for intranasal naloxone and medication assisted therapy initiatives. Her career interests include Rx drug abuse research, addiction treatment, and academia. Dowling is pursuing a Master of Public Health (community health concentration) from ETSU.
Community Pharmacists and Harm Reduction: Evidence and Opportunities
PharmD, Community Pharmacy Practice Research Fellow
Gatton College of Pharmacy, East Tennessee State University
KariLynn Dowling, PharmD, is a Community Pharmacy Practice Research Fellow and adjunct faculty member at East Tennessee State University (ETSU) Gatton College of Pharmacy. She is a 2014 graduate of the University of Montana Skaggs School of Pharmacy. She completed residency training at Penobscot Community Health Care in Bangor, Maine, as a member of the 2014-15 PGY1 Community Pharmacy and 2015-16 PGY2 Health-Systems Pharmacy Administration residency classes. As a resident, Dowling focused on controlled substance stewardship and program implementation for intranasal naloxone and medication assisted therapy initiatives. Her career interests include Rx drug abuse research, addiction treatment, and academia. Dowling is pursuing a Master of Public Health (community health concentration) from ETSU.
Community Pharmacists and Harm Reduction: Evidence and Opportunities
Karen Drexler
MD, National Mental Health Program Director - Substance Use Disorders, VACO
Veterans Health Administration, field-based at the Atlanta VA Medical Center
Dr. Karen Drexler serves as National Mental Health Program Director for Substance Use Disorders in the Office of Mental Health and Suicide Prevention in VA Central Office. She graduated from Duke University School of Medicine and completed her psychiatry residency at Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas. She served four years as a psychiatrist and Medical Director of the Alcohol Rehabilitation Center at Wright-Patterson Air Force Base and on the faculty at Wright State University School of Medicine in Dayton, Ohio. She is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she was Addiction Psychiatry Residency Training Director from 2002 to 2014. Her research interests include clinical trials in addiction treatment and translational research on the neurobiology of addiction. She serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry, and as a member of the Board of Directors of the Community Anti-Drug Coalitions of America. She continues to actively practice addiction psychiatry at the Atlanta VA Medical Center.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
MD, National Mental Health Program Director - Substance Use Disorders, VACO
Veterans Health Administration, field-based at the Atlanta VA Medical Center
Dr. Karen Drexler serves as National Mental Health Program Director for Substance Use Disorders in the Office of Mental Health and Suicide Prevention in VA Central Office. She graduated from Duke University School of Medicine and completed her psychiatry residency at Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas. She served four years as a psychiatrist and Medical Director of the Alcohol Rehabilitation Center at Wright-Patterson Air Force Base and on the faculty at Wright State University School of Medicine in Dayton, Ohio. She is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine, where she was Addiction Psychiatry Residency Training Director from 2002 to 2014. Her research interests include clinical trials in addiction treatment and translational research on the neurobiology of addiction. She serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry, and as a member of the Board of Directors of the Community Anti-Drug Coalitions of America. She continues to actively practice addiction psychiatry at the Atlanta VA Medical Center.
VA Best Practices: S.T.O.P. P.A.I.N Initiative and Practice Guidelines
John J. Dreyzehner
MD, MPH, FACOEM, Commissioner
Tennessee Department of Health, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
John J. Dreyzehner, MD, MPH, FACOEM, joined Gov. Bill Haslam’s cabinet Sept. 19, 2011, as the 12th Commissioner of the Tennessee Department of Health, having more than 20 years of service in clinical and public health leadership at the federal, state and local levels. He began his medical service in 1989 as a U.S. Air Force flight surgeon. Following honorable discharge as a Major, he spent several years practicing occupational medicine, joining the Virginia Department of Health in 2002. He also concurrently practiced addiction medicine for several years while working on substance abuse prevention in his public health role. Dreyzehner graduated from the University of Illinois at Champaign-Urbana Magna Cum Laude with a Bachelor of Science in psychology. He received his Doctor of Medicine from the University of Illinois at Chicago, and earned his Master of Public Health at the University of Utah, where he also completed his residency in occupational medicine. He and his wife Jana, a child psychiatrist, have two sons. Dreyzehner is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
MD, MPH, FACOEM, Commissioner
Tennessee Department of Health, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
John J. Dreyzehner, MD, MPH, FACOEM, joined Gov. Bill Haslam’s cabinet Sept. 19, 2011, as the 12th Commissioner of the Tennessee Department of Health, having more than 20 years of service in clinical and public health leadership at the federal, state and local levels. He began his medical service in 1989 as a U.S. Air Force flight surgeon. Following honorable discharge as a Major, he spent several years practicing occupational medicine, joining the Virginia Department of Health in 2002. He also concurrently practiced addiction medicine for several years while working on substance abuse prevention in his public health role. Dreyzehner graduated from the University of Illinois at Champaign-Urbana Magna Cum Laude with a Bachelor of Science in psychology. He received his Doctor of Medicine from the University of Illinois at Chicago, and earned his Master of Public Health at the University of Utah, where he also completed his residency in occupational medicine. He and his wife Jana, a child psychiatrist, have two sons. Dreyzehner is a member of the National Rx Drug Abuse & Heroin Summit Advisory Board.
Laura Dunlap
PhD, Senior Director, Behavioral Health Services, Policy and Economics Research
RTI International
Laura J. Dunlap, PhD, is Senior Director of RTI International’s Behavioral Health Services, Policy, and Economics Research Program. She has over 20 years of experience conducting evaluations of substance abuse treatment programs and the systems in which they provide services, including medication assisted treatment for opioid use disorders (OUDs). She currently serves as the Project Director for the Centers for Disease Control and Prevention-funded Evaluation of Medication Assisted Treatment. She recently led the Office of The Assistant Secretary for Planning and Evaluation-funded Telehealth study, which examined use of telehealth for expanding access to treatment of OUDs. She has led numerous research studies in the field of behavioral health on multiple federal contracts and grants, including for the Substance Abuse and Mental Health Services Administration and the National Institutes of Health. Dunlap has published her findings in numerous journals.
Expanding Access to OUD Treatment: The Role of Telehealth
PhD, Senior Director, Behavioral Health Services, Policy and Economics Research
RTI International
Laura J. Dunlap, PhD, is Senior Director of RTI International’s Behavioral Health Services, Policy, and Economics Research Program. She has over 20 years of experience conducting evaluations of substance abuse treatment programs and the systems in which they provide services, including medication assisted treatment for opioid use disorders (OUDs). She currently serves as the Project Director for the Centers for Disease Control and Prevention-funded Evaluation of Medication Assisted Treatment. She recently led the Office of The Assistant Secretary for Planning and Evaluation-funded Telehealth study, which examined use of telehealth for expanding access to treatment of OUDs. She has led numerous research studies in the field of behavioral health on multiple federal contracts and grants, including for the Substance Abuse and Mental Health Services Administration and the National Institutes of Health. Dunlap has published her findings in numerous journals.
Expanding Access to OUD Treatment: The Role of Telehealth
Robert DuPont MD
MD, President
Institute for Behavior and Health, Inc., and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
For over 40 years, Dr. Robert L. DuPont has been a leader in drug abuse prevention and treatment. He was the first Director of the National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970, he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978, he became the founding President of the Institute for Behavior and Health, Inc. He has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. He is a Distinguished Fellow of the American Society of Addiction Medicine and Life Fellow of the American Psychiatric Association. DuPont's signature role throughout his career has been to focus on the public health goal of reducing the use of illegal drugs.
The National Opioid Overdose Epidemic: It’s Not Just Opioids
Long-Term Recovery: The Essential Roles of Families and Addiction Treatment Providers
MD, President
Institute for Behavior and Health, Inc., and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
For over 40 years, Dr. Robert L. DuPont has been a leader in drug abuse prevention and treatment. He was the first Director of the National Institute on Drug Abuse (1973-1978) and the second White House Drug Chief (1973-1977). From 1968-1970, he was Director of Community Services for the District of Columbia Department of Corrections. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. In 1978, he became the founding President of the Institute for Behavior and Health, Inc. He has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. He is a Distinguished Fellow of the American Society of Addiction Medicine and Life Fellow of the American Psychiatric Association. DuPont's signature role throughout his career has been to focus on the public health goal of reducing the use of illegal drugs.
The National Opioid Overdose Epidemic: It’s Not Just Opioids
Long-Term Recovery: The Essential Roles of Families and Addiction Treatment Providers
Holly Dye
MRC, Beyond Birth Program Director
University of Kentucky HealthCare
Holly Dye, MRC, is a nationally recognized expert on addiction and the impact on children. After 20 years of work with foster children, in-patient and out-patient drug treatment settings, Dye created a model program for medical and behavioral health interventions with families impacted by substance abuse that utilized telehealth networks, a basic online training program and a 16-hour training curriculum for professionals. She has authored numerous publications, many specific to substance use disorders and child development, and has developed programs for parents with addiction. She is the recipient of the 2012 Bluegrass Alliance for Women, Impact Award; 2011 Department of Homeland Security Service Award; 2008 Victim Impact Program Service Award; 2006 Champion for Children Award, presented by Prevent Child Abuse Kentucky; and the 2007 Recognition Award by the Federal Medical Center for work done for the Victim Impact Program. She was featured in the A&E Special A Question of Life or Meth, which received the Daytime Emmy Award for Outstanding Special, June 14, 2007. Dye currently works as the Program Manager of the Beyond Birth at University of Kentucky HealthCare and the University of Kentucky, College of Nursing Perinatal Research Center in Lexington, Kentucky.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Abuse Treatment among Perinatal Women
MRC, Beyond Birth Program Director
University of Kentucky HealthCare
Holly Dye, MRC, is a nationally recognized expert on addiction and the impact on children. After 20 years of work with foster children, in-patient and out-patient drug treatment settings, Dye created a model program for medical and behavioral health interventions with families impacted by substance abuse that utilized telehealth networks, a basic online training program and a 16-hour training curriculum for professionals. She has authored numerous publications, many specific to substance use disorders and child development, and has developed programs for parents with addiction. She is the recipient of the 2012 Bluegrass Alliance for Women, Impact Award; 2011 Department of Homeland Security Service Award; 2008 Victim Impact Program Service Award; 2006 Champion for Children Award, presented by Prevent Child Abuse Kentucky; and the 2007 Recognition Award by the Federal Medical Center for work done for the Victim Impact Program. She was featured in the A&E Special A Question of Life or Meth, which received the Daytime Emmy Award for Outstanding Special, June 14, 2007. Dye currently works as the Program Manager of the Beyond Birth at University of Kentucky HealthCare and the University of Kentucky, College of Nursing Perinatal Research Center in Lexington, Kentucky.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Abuse Treatment among Perinatal Women
John Eadie, MPA
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.
Stimulants and Opioids: An Emerging Drug Threat in the Midst of the Opioid Epidemic
Coordinator, Public Health and Prescription Drug Monitoring Program Project
National Emerging Threat Initiative, A National HIDTA Initiative
John Eadie is the Public Health & Prescription Drug Monitoring Program project coordinator for the National Emerging Threat Initiative of the National HIDTA Assistance Center. He previously served as director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University (2010-2015). For 44 years, Eadie has served in management, executive and consulting capacities in the field of public health. As director of the Division of Public Health Protection in the New York State Department of Health (1985-1995), he directed the state’s pharmaceutical diversion program, including the PDMP. He co-founded both the Alliance of States with Prescription Monitoring Programs and the National Association of State Controlled Substances Authorities, served as president for both organizations and held other posts. Since leaving New York state service in 2001, Eadie has served as a consultant on PDMPs, including serving as the administrative reviewer for the Massachusetts PDMP.
Stimulants and Opioids: An Emerging Drug Threat in the Midst of the Opioid Epidemic
Harry Earle
MA, Chief of Police
Gloucester Township (New Jersey) Police Department
Harry Earle, MA, is the Chief of Police of the Gloucester Township Police Department in Camden County, New Jersey. He has served with the department since 1988 and been Chief since 2010. Earle has implemented numerous community and problem-solving policing models with a focus on overall crime prevention through new programs targeting at-risk youth and early victimization identification. Earle holds a bachelor's degree in criminal justice, a master’s degree in human resource development, and is a graduate of the FBI National Academy. Earle is the President of the Camden County Chiefs of Police Association, and serves on numerous boards and committees including the Camden County College Police Academy Advisory Board, the New Jersey Council on Juvenile Justice System Improvement, and the New Jersey Human Trafficking Commission. Earle has lectured on the topics of police professionalism, bullying, peer mediation, violence prevention in schools, community policing, addiction and prevention of child sexual exploitation.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
MA, Chief of Police
Gloucester Township (New Jersey) Police Department
Harry Earle, MA, is the Chief of Police of the Gloucester Township Police Department in Camden County, New Jersey. He has served with the department since 1988 and been Chief since 2010. Earle has implemented numerous community and problem-solving policing models with a focus on overall crime prevention through new programs targeting at-risk youth and early victimization identification. Earle holds a bachelor's degree in criminal justice, a master’s degree in human resource development, and is a graduate of the FBI National Academy. Earle is the President of the Camden County Chiefs of Police Association, and serves on numerous boards and committees including the Camden County College Police Academy Advisory Board, the New Jersey Council on Juvenile Justice System Improvement, and the New Jersey Human Trafficking Commission. Earle has lectured on the topics of police professionalism, bullying, peer mediation, violence prevention in schools, community policing, addiction and prevention of child sexual exploitation.
Changing Attitudes: Law Enforcement, Public Health and Naloxone
Paul Earley
MD, Georgia Professionals Health Program, Inc.
President-Elect, Federation of State Physician Health Programs
Dr. Paul Earley has been an addiction medicine physician for over 30 years. He specializes in the assessment, treatment and management of healthcare professionals with addictive disorders. He also works with patients already in recovery, providing long-term therapy. He is the author of two books and numerous articles on addiction and its treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) textbook, "The ASAM Principles of Addiction Medicine," and the ASAM criteria. His most recent book, "RecoveryMind Training," is an innovative and comprehensive process designed to reengineer addiction treatment. His work was featured in the documentary series on addiction entitled "Close to Home" by Bill Moyers. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program for the state of Georgia, and the President-elect of the Federation of State Physician Health Programs. He is the President-elect of ASAM. Earley is the recipient of the ASAM Annual Award in 2015.
Improving Addiction Outcomes: Lessons from the Physician Health Program Model
MD, Georgia Professionals Health Program, Inc.
President-Elect, Federation of State Physician Health Programs
Dr. Paul Earley has been an addiction medicine physician for over 30 years. He specializes in the assessment, treatment and management of healthcare professionals with addictive disorders. He also works with patients already in recovery, providing long-term therapy. He is the author of two books and numerous articles on addiction and its treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) textbook, "The ASAM Principles of Addiction Medicine," and the ASAM criteria. His most recent book, "RecoveryMind Training," is an innovative and comprehensive process designed to reengineer addiction treatment. His work was featured in the documentary series on addiction entitled "Close to Home" by Bill Moyers. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program for the state of Georgia, and the President-elect of the Federation of State Physician Health Programs. He is the President-elect of ASAM. Earley is the recipient of the ASAM Annual Award in 2015.
Improving Addiction Outcomes: Lessons from the Physician Health Program Model
Doug Edwards
Director
Institute for the Advancement of Behavioral Healthcare
Doug Edwards is Director of the Institute for the Advancement of Behavioral Healthcare, which produces the National Conference on Addiction Disorders, the National Rx Drug Abuse & Heroin Summit, the Summits for Clinical Excellence, and other conferences for behavioral healthcare professionals and allied stakeholders. He previously was the Editor-in-Chief and Publisher of both Addiction Professional and Behavioral Healthcare magazines. Edwards has been serving the mental health and addiction treatment community for more than 17 years. Noted for his behavioral healthcare market expertise, Edwards presents at conferences and moderates expert panel discussions around the country. He earned his master's degree in business administration from Franklin University and his bachelor's degree from The University of Akron.
Welcome and Opening Plenary Session
Director
Institute for the Advancement of Behavioral Healthcare
Doug Edwards is Director of the Institute for the Advancement of Behavioral Healthcare, which produces the National Conference on Addiction Disorders, the National Rx Drug Abuse & Heroin Summit, the Summits for Clinical Excellence, and other conferences for behavioral healthcare professionals and allied stakeholders. He previously was the Editor-in-Chief and Publisher of both Addiction Professional and Behavioral Healthcare magazines. Edwards has been serving the mental health and addiction treatment community for more than 17 years. Noted for his behavioral healthcare market expertise, Edwards presents at conferences and moderates expert panel discussions around the country. He earned his master's degree in business administration from Franklin University and his bachelor's degree from The University of Akron.
Welcome and Opening Plenary Session
Gary Enos
MS, Editor
Addiction Professional
Gary Enos has been editor of Addiction Professional since the publication’s inception in 2003. He has covered clinical, business and policy issues as an editor and reporter in the addiction and mental health fields since 1994. Enos also has moderated panels at numerous events for the Institute for the Advancement of Behavioral Healthcare, including the annual National Conference on Addiction Disorders (NCAD). Prior to his work in behavioral health, he was a reporter covering state and local government issues for Crain Communications’ City & State newspaper, and a government reporter at the Fort Lauderdale Sun-Sentinel. Enos is a graduate of Brown University and Northwestern University’s Medill School of Journalism.
MS, Editor
Addiction Professional
Gary Enos has been editor of Addiction Professional since the publication’s inception in 2003. He has covered clinical, business and policy issues as an editor and reporter in the addiction and mental health fields since 1994. Enos also has moderated panels at numerous events for the Institute for the Advancement of Behavioral Healthcare, including the annual National Conference on Addiction Disorders (NCAD). Prior to his work in behavioral health, he was a reporter covering state and local government issues for Crain Communications’ City & State newspaper, and a government reporter at the Fort Lauderdale Sun-Sentinel. Enos is a graduate of Brown University and Northwestern University’s Medill School of Journalism.
Jose' Esquibel
Director, Office of Community Engagement
Colorado Office of the Attorney General
Since 2013, José Esquibel has served as the Vice Chair of Prevention for the Colorado Statewide Substance Abuse Trend and Response Task Force, a legislatively mandated task force chaired by Attorney General Cynthia H. Coffman. His role includes active participation in a collaborative and comprehensive approach to addressing multiple issues related to Rx drug abuse through the Colorado Consortium for Prescription Drug Abuse Prevention. The consortium serves as the official Rx drug abuse prevention committee of the task force and is focused on implementing the goals of the Colorado Plan to Reduce Prescription Drug Abuse Prevention Plan related to public awareness, provider and prescriber education, the prescription drug monitoring program, and disposal of unused household medications. Esquibel's experience in substance abuse prevention includes work at the community level and within state government.
Colorado AmeriCorps Community Opioid Response Program
Director, Office of Community Engagement
Colorado Office of the Attorney General
Since 2013, José Esquibel has served as the Vice Chair of Prevention for the Colorado Statewide Substance Abuse Trend and Response Task Force, a legislatively mandated task force chaired by Attorney General Cynthia H. Coffman. His role includes active participation in a collaborative and comprehensive approach to addressing multiple issues related to Rx drug abuse through the Colorado Consortium for Prescription Drug Abuse Prevention. The consortium serves as the official Rx drug abuse prevention committee of the task force and is focused on implementing the goals of the Colorado Plan to Reduce Prescription Drug Abuse Prevention Plan related to public awareness, provider and prescriber education, the prescription drug monitoring program, and disposal of unused household medications. Esquibel's experience in substance abuse prevention includes work at the community level and within state government.
Colorado AmeriCorps Community Opioid Response Program
Greg Fabisiak
Environmental Integration Coordinator
Colorado Department of Public Health and Environment
Greg Fabisiak joined the Colorado Department of Public Health and Environment in 2009 following a 27-year career in water and wastewater utility management. As the department’s Environmental Integration Coordinator, he provides leadership in formulating and implementing approaches to address emerging environmental issues and those that fall outside of traditional, media-specific regulatory programs. This includes developing the department’s strategy to reduce impacts to public health and the environment from improperly disposed pharmaceuticals. In this role, Fabisiak manages the Colorado Household Medication Take-Back Program and works with a diverse group of stakeholders to expand and promote this program statewide, so that all residents have may access to safe and environmentally-sound options for medication disposal. Fabisiak also serves as co-chair of the Safe Disposal Work Group at the Colorado Consortium for Prescription Drug Abuse Prevention.
Safe Disposal in Colorado: A State-Led Approach
Environmental Integration Coordinator
Colorado Department of Public Health and Environment
Greg Fabisiak joined the Colorado Department of Public Health and Environment in 2009 following a 27-year career in water and wastewater utility management. As the department’s Environmental Integration Coordinator, he provides leadership in formulating and implementing approaches to address emerging environmental issues and those that fall outside of traditional, media-specific regulatory programs. This includes developing the department’s strategy to reduce impacts to public health and the environment from improperly disposed pharmaceuticals. In this role, Fabisiak manages the Colorado Household Medication Take-Back Program and works with a diverse group of stakeholders to expand and promote this program statewide, so that all residents have may access to safe and environmentally-sound options for medication disposal. Fabisiak also serves as co-chair of the Safe Disposal Work Group at the Colorado Consortium for Prescription Drug Abuse Prevention.
Safe Disposal in Colorado: A State-Led Approach
Laura Fanucchi
MD, MPH, Assistant Professor of Medicine
University of Kentucky
Laura Fanucchi, MD, MPH, is a general internist with additional board certification in addiction medicine. She obtained her medical degree from Emory University School of Medicine, completed internal medicine residency at New York Presbyterian Hospital Weill Cornell Medical College, and is currently Assistant Professor of Medicine at the University of Kentucky. Fanucchi’s clinical and research focus is on improving the care of hospitalized and medically complex patients with substance use disorders. She is currently providing treatment for opioid use disorder in HIV primary care at the University of Kentucky Bluegrass Care Clinic.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Abuse Treatment among Perinatal Women
MD, MPH, Assistant Professor of Medicine
University of Kentucky
Laura Fanucchi, MD, MPH, is a general internist with additional board certification in addiction medicine. She obtained her medical degree from Emory University School of Medicine, completed internal medicine residency at New York Presbyterian Hospital Weill Cornell Medical College, and is currently Assistant Professor of Medicine at the University of Kentucky. Fanucchi’s clinical and research focus is on improving the care of hospitalized and medically complex patients with substance use disorders. She is currently providing treatment for opioid use disorder in HIV primary care at the University of Kentucky Bluegrass Care Clinic.
Do the Next Right Thing: A Family-Centered and Multidisciplinary Approach to Substance Abuse Treatment among Perinatal Women
Victor Fazio
EdD, MACJ, Detective Sergeant
Ventura County (California) Sheriff’s Office
Victor Fazio has 23 years of law enforcement experience and has been assigned to the Narcotics Bureau at the Ventura County (California) Sheriff’s Office for over 15 years. He is considered an expert throughout the country in pharmaceutical drug diversion and heroin investigations. He began investigating criminally operating physicians and the unlawful practices of pharmaceutical companies in 2002. He was the architect and task force commander of the Ventura County Interagency Pharmaceutical Crimes Unit, which investigates any crime involving a pharmaceutical drug or heroin including drug dealing resulting in death. He supervises the Major Narcotics Violator team for the Ventura County Narcotics Task Force known as VCAT. Fazio has investigated and supervised many multi-jurisdictional / international cases involving both Rx drugs and heroin. He has instructed thousands of law enforcement officers, doctors, nurses, pharmacists and attorneys for the California Narcotics Officers Association, the National Association of Drug Diversion Investigators, and other agencies and organizations throughout the country. Fazio has a bachelor's degree in political science from the University of California, Los Angeles, a master's degree in criminal justice from Arizona State University, and a doctorate in education from the University of Southern California. His research interests are focused on reducing harms caused by opioids through physician education.
The Intersection of Law Enforcement and Healthcare: Increased Utilization of California's PDMP
EdD, MACJ, Detective Sergeant
Ventura County (California) Sheriff’s Office
Victor Fazio has 23 years of law enforcement experience and has been assigned to the Narcotics Bureau at the Ventura County (California) Sheriff’s Office for over 15 years. He is considered an expert throughout the country in pharmaceutical drug diversion and heroin investigations. He began investigating criminally operating physicians and the unlawful practices of pharmaceutical companies in 2002. He was the architect and task force commander of the Ventura County Interagency Pharmaceutical Crimes Unit, which investigates any crime involving a pharmaceutical drug or heroin including drug dealing resulting in death. He supervises the Major Narcotics Violator team for the Ventura County Narcotics Task Force known as VCAT. Fazio has investigated and supervised many multi-jurisdictional / international cases involving both Rx drugs and heroin. He has instructed thousands of law enforcement officers, doctors, nurses, pharmacists and attorneys for the California Narcotics Officers Association, the National Association of Drug Diversion Investigators, and other agencies and organizations throughout the country. Fazio has a bachelor's degree in political science from the University of California, Los Angeles, a master's degree in criminal justice from Arizona State University, and a doctorate in education from the University of Southern California. His research interests are focused on reducing harms caused by opioids through physician education.
The Intersection of Law Enforcement and Healthcare: Increased Utilization of California's PDMP
Sean T. Fearns
Chief, Community Outreach Section, Office of Congressional and Public Affairs
U.S. Drug Enforcement Administration
Sean Fearns has served as the Chief of Community Outreach for the U.S. Drug Enforcement Administration (DEA) since 2015, a position that includes management of the DEA Museum, as well as the DEA Community Outreach and Prevention Support section. In this capacity, Fearns is responsible for guiding a diverse and creative staff to develop and implement strategic national partnerships with other organizations that help educate the public on the current drug threats facing the country, communicate key Administration drug prevention messages, and reduce the demand for those drugs, including implementing the DEA 360 Strategy.
Update from the DEA Diversion Control Division
Chief, Community Outreach Section, Office of Congressional and Public Affairs
U.S. Drug Enforcement Administration
Sean Fearns has served as the Chief of Community Outreach for the U.S. Drug Enforcement Administration (DEA) since 2015, a position that includes management of the DEA Museum, as well as the DEA Community Outreach and Prevention Support section. In this capacity, Fearns is responsible for guiding a diverse and creative staff to develop and implement strategic national partnerships with other organizations that help educate the public on the current drug threats facing the country, communicate key Administration drug prevention messages, and reduce the demand for those drugs, including implementing the DEA 360 Strategy.
Update from the DEA Diversion Control Division
Karina Forrest-Perkins
MHR, LADC, Chief Executive Officer
The Wayside House, Inc.
Karina A. Forrest‐Perkins is a national speaker and consultant on systems improvement and primary care integration within the behavioral health field. Forrest-Perkins also serves as the Chief Executive Officer for The Wayside House, a women’s chemical dependency and co-occurring treatment center in Minneapolis, St. Louis Park, and St. Paul, Minnesota. Prior to this appointment, she served as the President and CEO of Prevent Child Abuse Minnesota and Minnesota Communities Caring for Children. Forrest-Perkins has served as a staff member or task force appointee in three Oklahoma governors’ administrations and is a current appointee to the Minnesota Governor’s Task Force on Medical Cannabis Research. In addition to her position as CEO of The Wayside House, she has served in executive roles in residential adolescent co-occurring treatment, outpatient co-occurring treatment and substance abuse prevention. She currently consults as a subject matter expert for the National Addiction Technology Transfer Center, Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Excellence on Opioid Abuse for Pregnant and Postpartum Women, and SAMHSA’s Center for the Application of Prevention Technologies. Forrest-Perkins is a 2017 Bush Foundation Leadership Fellow and lives in Robbinsdale with her husband, Jack, and cat, Gus.
Opioid Prevention 2.0: Innovative Strategies for Staying Ahead of the Trends
MHR, LADC, Chief Executive Officer
The Wayside House, Inc.
Karina A. Forrest‐Perkins is a national speaker and consultant on systems improvement and primary care integration within the behavioral health field. Forrest-Perkins also serves as the Chief Executive Officer for The Wayside House, a women’s chemical dependency and co-occurring treatment center in Minneapolis, St. Louis Park, and St. Paul, Minnesota. Prior to this appointment, she served as the President and CEO of Prevent Child Abuse Minnesota and Minnesota Communities Caring for Children. Forrest-Perkins has served as a staff member or task force appointee in three Oklahoma governors’ administrations and is a current appointee to the Minnesota Governor’s Task Force on Medical Cannabis Research. In addition to her position as CEO of The Wayside House, she has served in executive roles in residential adolescent co-occurring treatment, outpatient co-occurring treatment and substance abuse prevention. She currently consults as a subject matter expert for the National Addiction Technology Transfer Center, Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Excellence on Opioid Abuse for Pregnant and Postpartum Women, and SAMHSA’s Center for the Application of Prevention Technologies. Forrest-Perkins is a 2017 Bush Foundation Leadership Fellow and lives in Robbinsdale with her husband, Jack, and cat, Gus.
Opioid Prevention 2.0: Innovative Strategies for Staying Ahead of the Trends
Shai Fuxman
EdD, Senior Research Scientist
Education Development Center
Dr. Shai Fuxman, a Senior Research Scientist with the Education Development Center, is an experienced researcher in the fields of public health and education. He serves as a Senior Training and Technical Assistance Associate for the Substance Abuse and Mental Health Services Administration's Center for the Application of Prevention Technologies (CAPT), a training and technical assistance center supporting the substance abuse prevention efforts of the country’s states, tribes and jurisdictions. At the CAPT, Fuxman leads the opioid response team, providing research and technical support to states and communities regarding best practices for reducing opioid misuse and overdoses. He has presented to various audiences on risky and protective factors related to opioid misuse, as well as effective strategies for reducing opioid misuse. His subject and skill expertise include positive and healthy youth development, program evaluation, and culturally responsive approaches to health promotion. He has published articles on efforts to engage parents and youth in efforts to reduce risky behaviors among youth. He earned his doctorate and master’s degrees in education from Harvard University’s Graduate School of Education and his bachelor’s degree from Brandeis University.
Opioid Prevention 2.0: Innovative Strategies for Staying Ahead of the Trends
EdD, Senior Research Scientist
Education Development Center
Dr. Shai Fuxman, a Senior Research Scientist with the Education Development Center, is an experienced researcher in the fields of public health and education. He serves as a Senior Training and Technical Assistance Associate for the Substance Abuse and Mental Health Services Administration's Center for the Application of Prevention Technologies (CAPT), a training and technical assistance center supporting the substance abuse prevention efforts of the country’s states, tribes and jurisdictions. At the CAPT, Fuxman leads the opioid response team, providing research and technical support to states and communities regarding best practices for reducing opioid misuse and overdoses. He has presented to various audiences on risky and protective factors related to opioid misuse, as well as effective strategies for reducing opioid misuse. His subject and skill expertise include positive and healthy youth development, program evaluation, and culturally responsive approaches to health promotion. He has published articles on efforts to engage parents and youth in efforts to reduce risky behaviors among youth. He earned his doctorate and master’s degrees in education from Harvard University’s Graduate School of Education and his bachelor’s degree from Brandeis University.
Opioid Prevention 2.0: Innovative Strategies for Staying Ahead of the Trends
Luigi F. Garcia Saavedra
MPH, Substance Use Epidemiologist Supervisor
New Mexico Department of Health
Luigi F. Garcia Saavedra was born and raised in Lima, Peru. His undergraduate studies were made at Universidad Peruana Cayetano Heredia, from where he graduated with a major in Science with focus in Biology. In Lima, he undertook advanced studies in Biochemistry and Molecular Biology and worked as teacher and researcher. In 2013 he graduated from the Masters in Public Health program at University of New Mexico, with a concentration in Epidemiology. In 2014 he joined the New Mexico Department of Health as Substance Abuse Epidemiologist, where he focused on surveillance, epidemiology translation, and data analysis on substance abuse. In May 2017 became the Substance Use Epidemiologist Supervisor under the NM Enhanced State Opioid Overdose Surveillance grant.
States with Fast Data: Lessons Learned from Kentucky, New Mexico and Wisconsin
MPH, Substance Use Epidemiologist Supervisor
New Mexico Department of Health
Luigi F. Garcia Saavedra was born and raised in Lima, Peru. His undergraduate studies were made at Universidad Peruana Cayetano Heredia, from where he graduated with a major in Science with focus in Biology. In Lima, he undertook advanced studies in Biochemistry and Molecular Biology and worked as teacher and researcher. In 2013 he graduated from the Masters in Public Health program at University of New Mexico, with a concentration in Epidemiology. In 2014 he joined the New Mexico Department of Health as Substance Abuse Epidemiologist, where he focused on surveillance, epidemiology translation, and data analysis on substance abuse. In May 2017 became the Substance Use Epidemiologist Supervisor under the NM Enhanced State Opioid Overdose Surveillance grant.
States with Fast Data: Lessons Learned from Kentucky, New Mexico and Wisconsin
Trip Gardner
MD, Chief Psychiatric Officer and Medical Director of Homeless Health Services
Penobscot Community Health Care
Dr. Trip Gardner is the Chief Psychiatric Officer and Medical Director of Homeless Health Services at Penobscot Community Health Care (PCHC), a Federally Qualified Health Center in Bangor, Maine. PCHC provides 350,000 patient visits a year to 65,000 individuals, in 16 locations. In 2004, Gardner created a model that fully integrates mental health services including addiction into primary care. He has presented about integration more than 25 times throughout the country and has served on expert panels for HRSA, SAMHSA and NACHC. Gardner was the project director of the 2005 “Integrated Medical, Mental Health and Substance Abuse Services for People Who are Homeless” Robert Wood Johnson Foundation grant that helped establish the first homeless health center in the country to receive level 3 Patient Centered Medical Home certification. This homeless health center was featured in the Agency for Healthcare Research and Quality’s “A Guidebook of Professional Practices for Behavioral Health and Primary Care Integration.” Gardner previously served for three years as a regional Medical Director for the State of Maine Department of Behavioral and Developmental Services.
Pharmacists and Physicians: Strategies for Effective Collaboration in Pain Management and MAT
MD, Chief Psychiatric Officer and Medical Director of Homeless Health Services
Penobscot Community Health Care
Dr. Trip Gardner is the Chief Psychiatric Officer and Medical Director of Homeless Health Services at Penobscot Community Health Care (PCHC), a Federally Qualified Health Center in Bangor, Maine. PCHC provides 350,000 patient visits a year to 65,000 individuals, in 16 locations. In 2004, Gardner created a model that fully integrates mental health services including addiction into primary care. He has presented about integration more than 25 times throughout the country and has served on expert panels for HRSA, SAMHSA and NACHC. Gardner was the project director of the 2005 “Integrated Medical, Mental Health and Substance Abuse Services for People Who are Homeless” Robert Wood Johnson Foundation grant that helped establish the first homeless health center in the country to receive level 3 Patient Centered Medical Home certification. This homeless health center was featured in the Agency for Healthcare Research and Quality’s “A Guidebook of Professional Practices for Behavioral Health and Primary Care Integration.” Gardner previously served for three years as a regional Medical Director for the State of Maine Department of Behavioral and Developmental Services.
Pharmacists and Physicians: Strategies for Effective Collaboration in Pain Management and MAT
